메뉴 건너뛰기




Volumn 10, Issue 4, 2009, Pages 663-672

Fibromyalgia symptoms are reduced by low-dose naltrexone: A pilot study

Author keywords

Chronic pain; Fibromyalgia; Low dose; Microglia; Naltrexone; Novel treatment

Indexed keywords

NALTREXONE; OPIATE ANTAGONIST; PLACEBO;

EID: 67049165566     PISSN: 15262375     EISSN: 15264637     Source Type: Journal    
DOI: 10.1111/j.1526-4637.2009.00613.x     Document Type: Article
Times cited : (167)

References (50)
  • 2
    • 0033013527 scopus 로고    scopus 로고
    • The London fibromyalgia study: The prevalence of fibromyalgia syndrome in London, Ontario
    • White KP, Speechley M, Harth M, et al. The London fibromyalgia study: The prevalence of fibromyalgia syndrome in London, Ontario. J Rheumatol 1999;26:1570-6.
    • (1999) J Rheumatol , vol.26 , pp. 1570-1576
    • White, K.P.1    Speechley, M.2    Harth, M.3
  • 3
    • 0026747899 scopus 로고
    • Towards a model of pathophysiology of fibromyalgia: Aberrant central pain mechanisms with peripheral modulation
    • Yunus MB. Towards a model of pathophysiology of fibromyalgia: Aberrant central pain mechanisms with peripheral modulation. J Rheumatol 1992;19:846-50.
    • (1992) J Rheumatol , vol.19 , pp. 846-850
    • Yunus, M.B.1
  • 4
    • 0027092651 scopus 로고
    • Fibromyalgia syndrome. New associations
    • Waylonis GW, Heck W. Fibromyalgia syndrome. New associations. Am J Phys Med Rehabil 1992;71:343-8.
    • (1992) Am J Phys Med Rehabil , vol.71 , pp. 343-348
    • Waylonis, G.W.1    Heck, W.2
  • 6
    • 0025828004 scopus 로고
    • Toward an integrated understanding of fibromyalgia syndrome. I. Medical and pathophysiological aspects
    • Boissevain MD, McCain GA. Toward an integrated understanding of fibromyalgia syndrome. I. Medical and pathophysiological aspects. Pain 1991;45:227-38.
    • (1991) Pain , vol.45 , pp. 227-238
    • Boissevain, M.D.1    McCain, G.A.2
  • 8
    • 53549086775 scopus 로고    scopus 로고
    • Fibromyalgia syndrome: A relevant recent construction of an ancient condition?
    • Perrot S. Fibromyalgia syndrome: A relevant recent construction of an ancient condition? Curr Opin Support Palliat Care 2008;2:122-7.
    • (2008) Curr Opin Support Palliat Care , vol.2 , pp. 122-127
    • Perrot, S.1
  • 9
    • 47349107934 scopus 로고    scopus 로고
    • Central nervous system abnormalities in fibromyalgia and chronic fatigue syndrome: New concepts in treatment
    • Gur A, Oktayoglu P. Central nervous system abnormalities in fibromyalgia and chronic fatigue syndrome: New concepts in treatment. Curr Pharm Des 2008;14:1274-94.
    • (2008) Curr Pharm Des , vol.14 , pp. 1274-1294
    • Gur, A.1    Oktayoglu, P.2
  • 11
    • 0036711111 scopus 로고    scopus 로고
    • Enhanced temporal summation of second pain and its central modulation in fibromyalgia patients
    • Price DD, Staud R, Robinson ME, et al. Enhanced temporal summation of second pain and its central modulation in fibromyalgia patients. Pain 2002;99:49-59.
    • (2002) Pain , vol.99 , pp. 49-59
    • Price, D.D.1    Staud, R.2    Robinson, M.E.3
  • 12
    • 23444450943 scopus 로고    scopus 로고
    • Fibromyalgia syndrome: Review of clinical presentation, pathogenesis, outcome measures, and treatment
    • Mease P. Fibromyalgia syndrome: Review of clinical presentation, pathogenesis, outcome measures, and treatment. J Rheumatol Suppl 2005;75:6-21.
    • (2005) J Rheumatol Suppl , vol.75 , pp. 6-21
    • Mease, P.1
  • 13
    • 34248636796 scopus 로고    scopus 로고
    • New insights into the pathogenesis of fibromyalgia syndrome: Important role of peripheral and central pain mechanisms
    • Staud R. New insights into the pathogenesis of fibromyalgia syndrome: Important role of peripheral and central pain mechanisms. Curr Rheumatol Rev 2007;3:113-21.
    • (2007) Curr Rheumatol Rev , vol.3 , pp. 113-121
    • Staud, R.1
  • 14
    • 34248665817 scopus 로고    scopus 로고
    • Fibromyalgia and overlapping disorders: The unifying concept of central sensitivity syndromes
    • Yunus MB. Fibromyalgia and overlapping disorders: The unifying concept of central sensitivity syndromes. Semin Arthritis Rheum 2007;36:339-56.
    • (2007) Semin Arthritis Rheum , vol.36 , pp. 339-356
    • Yunus, M.B.1
  • 15
    • 0642335532 scopus 로고    scopus 로고
    • Fibromyalgia, hepatitis C infection, and the cytokine connection
    • Thompson ME, Barkhuizen A. Fibromyalgia, hepatitis C infection, and the cytokine connection. Curr Pain Headache Rep 2003;7:342-7.
    • (2003) Curr Pain Headache Rep , vol.7 , pp. 342-347
    • Thompson, M.E.1    Barkhuizen, A.2
  • 16
    • 33644859724 scopus 로고    scopus 로고
    • Is there a role for cytokine based therapies in fibromyalgia
    • Wallace DJ. Is there a role for cytokine based therapies in fibromyalgia. Curr Pharm Des 2006;12:17-22.
    • (2006) Curr Pharm Des , vol.12 , pp. 17-22
    • Wallace, D.J.1
  • 17
    • 34249803311 scopus 로고    scopus 로고
    • Cytokine patterns in fibromyalgia and their correlation with clinical manifestations
    • Bazzichi L, Rossi A, Massimetti G, et al. Cytokine patterns in fibromyalgia and their correlation with clinical manifestations. Clin Exp Rheumatol 2007;25:225-30.
    • (2007) Clin Exp Rheumatol , vol.25 , pp. 225-230
    • Bazzichi, L.1    Rossi, A.2    Massimetti, G.3
  • 18
    • 20244389715 scopus 로고    scopus 로고
    • Pregabalin for the treatment of fibromyalgia syndrome: Results of a randomized, double-blind, placebo-controlled trial
    • Crofford LJ, Rowbotham MC, Mease PJ, et al. Pregabalin for the treatment of fibromyalgia syndrome: Results of a randomized, double-blind, placebo-controlled trial. American College of Rheumatology 2005;52:1264-73.
    • (2005) American College of Rheumatology , vol.52 , pp. 1264-1273
    • Crofford, L.J.1    Rowbotham, M.C.2    Mease, P.J.3
  • 19
    • 4444381930 scopus 로고    scopus 로고
    • A double-blind, multicenter trial comparing duloxetine with placebo in the treatment of fibromyalgia patients with or without major depressive disorder
    • Arnold LM, Lu Y, Crofford LJ, et al. A double-blind, multicenter trial comparing duloxetine with placebo in the treatment of fibromyalgia patients with or without major depressive disorder. Arthritis Rheum 2004;50:2974-84.
    • (2004) Arthritis Rheum , vol.50 , pp. 2974-2984
    • Arnold, L.M.1    Lu, Y.2    Crofford, L.J.3
  • 20
    • 26444518188 scopus 로고    scopus 로고
    • Efficacy of milnacipran in patients with fibromyalgia
    • Gendreau RM, Thorn MD, Gendreau JF, et al. Efficacy of milnacipran in patients with fibromyalgia. J Rheumatol 2005;32:1975-85.
    • (2005) J Rheumatol , vol.32 , pp. 1975-1985
    • Gendreau, R.M.1    Thorn, M.D.2    Gendreau, J.F.3
  • 21
    • 58849097195 scopus 로고    scopus 로고
    • Fibromyalgia: A review of its pathophysiology and drug treatment
    • Krypel LL. Fibromyalgia: A review of its pathophysiology and drug treatment. J Pharm Pract 2009;22:6-16.
    • (2009) J Pharm Pract , vol.22 , pp. 6-16
    • Krypel, L.L.1
  • 22
    • 41549092667 scopus 로고    scopus 로고
    • Pharmacological treatments of fibromyalgia: Do complex conditions need complex therapies?
    • Lawson K. Pharmacological treatments of fibromyalgia: Do complex conditions need complex therapies? Drug Discov Today 2008;13:333-40.
    • (2008) Drug Discov Today , vol.13 , pp. 333-340
    • Lawson, K.1
  • 23
    • 0037209098 scopus 로고    scopus 로고
    • Neuroprotective effect of naloxone in inflammation-mediated dopaminergic neurodegeneration: Dissociation from the involvement of opioid receptors
    • Liu B, Hong JS. Neuroprotective effect of naloxone in inflammation-mediated dopaminergic neurodegeneration: Dissociation from the involvement of opioid receptors. Methods Mol Med 2002;79:43-54.
    • (2002) Methods Mol Med , vol.79 , pp. 43-54
    • Liu, B.1    Hong, J.S.2
  • 24
    • 0034072541 scopus 로고    scopus 로고
    • Reduction by naloxone of lipopolysaccharide-induced neurotoxicity in mouse cortical neuron-glia co-cultures
    • Liu B, Du L, Kong L-Y, et al. Reduction by naloxone of lipopolysaccharide-induced neurotoxicity in mouse cortical neuron-glia co-cultures. Neuroscience 2000;97:749-56.
    • (2000) Neuroscience , vol.97 , pp. 749-756
    • Liu, B.1    Du, L.2    Kong, L.-Y.3
  • 25
    • 0027527271 scopus 로고
    • Peripheral mechanisms of opioid antinociception in inflammation: Involvement of cytokines
    • Czlonkowski A, Stein C, Harz A. Peripheral mechanisms of opioid antinociception in inflammation: Involvement of cytokines. Eur J Pharmacol 1993;242:229-35.
    • (1993) Eur J Pharmacol , vol.242 , pp. 229-235
    • Czlonkowski, A.1    Stein, C.2    Harz, A.3
  • 26
    • 3242717651 scopus 로고    scopus 로고
    • The opioid antagonist naltrexone blocks acute endotoxic shock by inhibiting tumor necrosis factor-alpha production
    • Greeneltch KM, Haudenschild CC, Keegan AD, et al. The opioid antagonist naltrexone blocks acute endotoxic shock by inhibiting tumor necrosis factor-alpha production. Brain Behav Immun 2004;18:476-84.
    • (2004) Brain Behav Immun , vol.18 , pp. 476-484
    • Greeneltch, K.M.1    Haudenschild, C.C.2    Keegan, A.D.3
  • 27
    • 0034015558 scopus 로고    scopus 로고
    • Naloxone protects rat dopaminergic neurons against inflammatory damage through inhibition of microglia activation and superoxide generation
    • Liu B, Du L, Hong JS. Naloxone protects rat dopaminergic neurons against inflammatory damage through inhibition of microglia activation and superoxide generation. J Pharmacol Exp Ther 2000;293:607-17.
    • (2000) J Pharmacol Exp Ther , vol.293 , pp. 607-617
    • Liu, B.1    Du, L.2    Hong, J.S.3
  • 28
    • 51749085166 scopus 로고    scopus 로고
    • Ultra-low-dose naloxone restores the antinociceptive effect of morphine and suppresses spinal neuroinflammation in PTX-treated rats
    • Tsai RY, Jang FL, Tai YH, et al. Ultra-low-dose naloxone restores the antinociceptive effect of morphine and suppresses spinal neuroinflammation in PTX-treated rats. Neuropsychopharmacology 2008;33:2772-82.
    • (2008) Neuropsychopharmacology , vol.33 , pp. 2772-2782
    • Tsai, R.Y.1    Jang, F.L.2    Tai, Y.H.3
  • 29
    • 0033810830 scopus 로고    scopus 로고
    • Systemic infusion of naloxone reduces degeneration of rat substantia nigral dopaminergic neurons induced by intranigral injection of lipopolysaccharide
    • Liu B, Jiang JW, Wilson BC, et al. Systemic infusion of naloxone reduces degeneration of rat substantia nigral dopaminergic neurons induced by intranigral injection of lipopolysaccharide. J Pharmacol Exp Ther 2000;295:125-32.
    • (2000) J Pharmacol Exp Ther , vol.295 , pp. 125-132
    • Liu, B.1    Jiang, J.W.2    Wilson, B.C.3
  • 30
    • 54049124717 scopus 로고    scopus 로고
    • Non-stereoselective reversal of neuropathic pain by naloxone and naltrexone: Involvement of toll-like receptor 4 (TLR4)
    • Hutchinson MR, Zhang Y, Brown K, et al. Non-stereoselective reversal of neuropathic pain by naloxone and naltrexone: Involvement of toll-like receptor 4 (TLR4). European Journal of Neuroscience 2008;28:20-9.
    • (2008) European Journal of Neuroscience , vol.28 , pp. 20-29
    • Hutchinson, M.R.1    Zhang, Y.2    Brown, K.3
  • 31
    • 33745747088 scopus 로고    scopus 로고
    • Modulation of brain apoptosis-related proteins by the opioid antagonist naltrexone in mice
    • San-Emeterio EP, Hurlé MA. Modulation of brain apoptosis-related proteins by the opioid antagonist naltrexone in mice. Neurosci Lett 2006;403:276-9.
    • (2006) Neurosci Lett , vol.403 , pp. 276-279
    • San-Emeterio, E.P.1    Hurlé, M.A.2
  • 32
    • 0028895234 scopus 로고
    • Treatment of neurotoxic side effects of interferon-alpha with naltrexone
    • Valentine AD, Meyers CA, Talpaz M. Treatment of neurotoxic side effects of interferon-alpha with naltrexone. Cancer Invest 1995;13:561-6.
    • (1995) Cancer Invest , vol.13 , pp. 561-566
    • Valentine, A.D.1    Meyers, C.A.2    Talpaz, M.3
  • 33
    • 33947666146 scopus 로고    scopus 로고
    • Low-dose naltrexone therapy improves active Crohn's disease
    • Smith JP, Stock H, Bigaman S, et al. Low-dose naltrexone therapy improves active Crohn's disease. Am J of Gastroenterol 2007;102:820-8.
    • (2007) Am J of Gastroenterol , vol.102 , pp. 820-828
    • Smith, J.P.1    Stock, H.2    Bigaman, S.3
  • 34
    • 58149337463 scopus 로고    scopus 로고
    • A pilot trial of low-dose naltrexone in primary progressive multiple sclerosis
    • Gironi M, Martinelli-Boneschi F, Sacerdote P, et al. A pilot trial of low-dose naltrexone in primary progressive multiple sclerosis. Mult Scler 2008;14:1076-83.
    • (2008) Mult Scler , vol.14 , pp. 1076-1083
    • Gironi, M.1    Martinelli-Boneschi, F.2    Sacerdote, P.3
  • 35
    • 0025266660 scopus 로고
    • The American College of Rheumatology 1990 criteria for the classification of fibromyalgia: Report of the Multicenter Criteria Committee
    • Wolfe F, Smythe HA, Yunus MB, et al. The American College of Rheumatology 1990 criteria for the classification of fibromyalgia: Report of the Multicenter Criteria Committee. Arthritis Rheum 1990;33:160-72.
    • (1990) Arthritis Rheum , vol.33 , pp. 160-172
    • Wolfe, F.1    Smythe, H.A.2    Yunus, M.B.3
  • 36
    • 1642380769 scopus 로고    scopus 로고
    • Is a single-item visual analogue scale as valid, reliable, and responsive as multi-item scales in measuring quality of life?
    • de Boer AGEM, van Lanschot JJB, Stalmeier PFM, et al. Is a single-item visual analogue scale as valid, reliable, and responsive as multi-item scales in measuring quality of life? Qual Life Res 2004;13:311-20.
    • (2004) Qual Life Res , vol.13 , pp. 311-320
    • de Boer, A.G.E.M.1    van Lanschot, J.J.B.2    Stalmeier, P.F.M.3
  • 37
    • 0026165648 scopus 로고
    • The fibromyalgia impact questionnaire: Development and validation
    • Burckhardt CS, Clark SR, Bennett RM. The fibromyalgia impact questionnaire: Development and validation. J Rheumatol 1991;18:728-33.
    • (1991) J Rheumatol , vol.18 , pp. 728-733
    • Burckhardt, C.S.1    Clark, S.R.2    Bennett, R.M.3
  • 38
    • 0035733108 scopus 로고    scopus 로고
    • The control of false discovery rate under dependency
    • Bejamini Y, Yekutieli D. The control of false discovery rate under dependency. Ann Stat 2001;29:1165-88.
    • (2001) Ann Stat , vol.29 , pp. 1165-1188
    • Bejamini, Y.1    Yekutieli, D.2
  • 39
    • 33749238682 scopus 로고    scopus 로고
    • Beyond Bonferroni: Less conservative analyses for conservation genetics
    • Narum SR. Beyond Bonferroni: Less conservative analyses for conservation genetics. Conserv Genet 2006;7:783-7.
    • (2006) Conserv Genet , vol.7 , pp. 783-787
    • Narum, S.R.1
  • 40
    • 0034748159 scopus 로고    scopus 로고
    • Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale
    • Farrar JT, Young JP, LaMoreaux L, et al. Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale. Pain 2001;94:149-58.
    • (2001) Pain , vol.94 , pp. 149-158
    • Farrar, J.T.1    Young, J.P.2    LaMoreaux, L.3
  • 41
    • 34547145165 scopus 로고    scopus 로고
    • G*Power 3: A flexible statistical power analysis program for the social, behavioral, and biomedical sciences
    • Faul F, Erdfelder E, G Lang A-G, Buchner A. G*Power 3: A flexible statistical power analysis program for the social, behavioral, and biomedical sciences. Behav Res Methods 2007;39:175-91.
    • (2007) , vol.39 , pp. 175-191
    • Faul, F.1    Erdfelder, E.G.2    Lang, A.-G.3    Buchner, A.4
  • 42
    • 0027207366 scopus 로고
    • Pain intensity in patients with fibromyalgia and rheumatoid arthritis
    • Viitanen JV, Kautiainen H, Isomäki H. Pain intensity in patients with fibromyalgia and rheumatoid arthritis. Scand J Rheumatol 1993;22:131-5.
    • (1993) Scand J Rheumatol , vol.22 , pp. 131-135
    • Viitanen, J.V.1    Kautiainen, H.2    Isomäki, H.3
  • 43
    • 10444286617 scopus 로고    scopus 로고
    • The DAS28 in rheumatoid arthritis and fibromyalgia patients
    • Leeb BF, Andel I, Sautner J, et al. The DAS28 in rheumatoid arthritis and fibromyalgia patients. Rheumatology 2004;43:1504-7.
    • (2004) Rheumatology , vol.43 , pp. 1504-1507
    • Leeb, B.F.1    Andel, I.2    Sautner, J.3
  • 44
    • 33845866350 scopus 로고    scopus 로고
    • The frequency of thyroid antibodies in fibromyalgia patients and their relationship with symptoms
    • Pamuk Ö, Çakir N. The frequency of thyroid antibodies in fibromyalgia patients and their relationship with symptoms. Clin Rheumatol 2007;26:55-9.
    • (2007) Clin Rheumatol , vol.26 , pp. 55-59
    • Pamuk, Ö.1    Çakir, N.2
  • 45
    • 0142040426 scopus 로고    scopus 로고
    • Subgrouping of fibromyalgia patients on the basis in pressure-pain thresholds and psychological factors
    • Giesecke T, Williams DA, Harris RE. Subgrouping of fibromyalgia patients on the basis in pressure-pain thresholds and psychological factors. Arthritis Rheum 2003;48:2916-22.
    • (2003) Arthritis Rheum , vol.48 , pp. 2916-2922
    • Giesecke, T.1    Williams, D.A.2    Harris, R.E.3
  • 46
    • 0037980445 scopus 로고    scopus 로고
    • Economic cost and epidemiological characteristics of patients with fibromyalgia claims
    • Robinson RL, Birnbaum HG, Morley MA, et al. Economic cost and epidemiological characteristics of patients with fibromyalgia claims. J Rheum 2003;30:1318-25.
    • (2003) J Rheum , vol.30 , pp. 1318-1325
    • Robinson, R.L.1    Birnbaum, H.G.2    Morley, M.A.3
  • 47
    • 3042806295 scopus 로고    scopus 로고
    • Direct and indirect costs of fibromyalgia in women
    • Penrod J, Adam V, Bernatsky S, et al. Direct and indirect costs of fibromyalgia in women. J Rheum 2004;31:1391-8.
    • (2004) J Rheum , vol.31 , pp. 1391-1398
    • Penrod, J.1    Adam, V.2    Bernatsky, S.3
  • 48
    • 0009538663 scopus 로고
    • Naltrexone and hepatotoxicity
    • Mitchell JE. Naltrexone and hepatotoxicity. Lancet 1986;1:1215.
    • (1986) Lancet , vol.1 , pp. 1215
    • Mitchell, J.E.1
  • 50
    • 34548201190 scopus 로고    scopus 로고
    • The high affinity peripheral benzodiazepine receptor ligand DAA1106 binds specifically to microglia in a rat model of traumatic brain injury: Implications for PET imaging
    • Venneti S, Wagner AK, Wang G, et al. The high affinity peripheral benzodiazepine receptor ligand DAA1106 binds specifically to microglia in a rat model of traumatic brain injury: Implications for PET imaging. Exp Neurol 2007;207:118-27.
    • (2007) Exp Neurol , vol.207 , pp. 118-127
    • Venneti, S.1    Wagner, A.K.2    Wang, G.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.